School of Medicine
Showing 1-10 of 63 Results
-
Russ B. Altman
Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine (General Medical Discipline), of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsI refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/
-
Euan A. Ashley
Associate Dean, School of Medicine, Professor of Medicine (Cardiovascular), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology at the Stanford University Medical Center
Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.
-
Carlos Bustamante
Professor of Biomedical Data Science, of Genetics and, by courtesy, of Biology
Current Research and Scholarly InterestsMy genetics research focuses on analyzing genome wide patterns of variation within and between species to address fundamental questions in biology, anthropology, and medicine. We focus on novel methods development for complex disease genetics and risk prediction in multi-ethnic settings. I am also interested in clinical data science and development of new diagnostics.I am also interested in disruptive innovation for healthcare including modeling long-term risk shifts and novel payment models.
-
Michelle Whirl-Carrillo
Senior Research Scientist, Biomedical Data Science
Current Role at StanfordPharmGKB Director
www.pharmgkb.org -
Helio Costa
Instructor, Pathology
Instructor, Biomedical Data ScienceBioHelio Costa, PhD, is a geneticist with expertise in genomics, molecular biology, molecular oncology, and bioinformatics. He is currently an Instructor within the Departments of Pathology and Biomedical Data Science at Stanford Medical School. Dr. Costa's research utilizes next-generation sequencing to develop new clinical genome and transcriptome profiling methods with the end goal of translating these tools to clinical diagnostic tests for implementation at Stanford Health Care. His research group is also interested in developing data science and machine learning methods to model and predict clinical outcomes and aid in clinical decision support. He is the founding director of the Stanford Clinical Data Science Fellowship where post-doctoral fellows engage in interdisciplinary clinical research and embed in health care workflows learning, building and deploying real-world health data solutions in the Stanford Health Care system. Additionally, he is an Attending Geneticist, and Assistant Lab Director of the Molecular Genetic Pathology Laboratory for Stanford Health Care. Dr. Costa received his BS in Genetics from University of California, Davis, his PhD in Genetics from Stanford University School of Medicine, and his ABMGG Clinical Molecular Genetics and Genomics fellowship training from Stanford University School of Medicine.
-
Mark R. Cullen, MD
Director, Center for Population Health Sciences, Professor of Medicine, of Biomedical Data Science, of Health Research & Policy & Senior Fellow at the Stanford Institute for Economic Policy Research
Current Research and Scholarly InterestsSocial and environmental determinants of health; role of workplace physical environment and work organization as causes of chronic disease and disability
-
Francisco De La Vega
Adjunct Professor, Biomedical Data Science
BioProf. Francisco M. De La Vega is a geneticist and computational biologist with interests in cancer, population, and clinical genomics, and with extensive experience in the life sciences industry. He is a Distinguished Scientific Fellow and Vice President of Bioinformatics and at TOMA Biosciences, a privately held start-up company commercializing a technology for precision oncology derived from inventions at Stanford. Francisco is also Adjunct Professor in the Department of Biomedical Data science of the Stanford School of Medicine, a Director of the International Society of Computational Biology, and is or has been a member of the Steering Committee of the NIST-led Genome-in-a-Bottle consortium, the PanCancer Analysis of Whole Genomes project of the ICGC, and the Steering Committee of the 1000 Genomes Project. He has more recently contributed to start-up companies in the life sciences area in positions such as CSO (Annai Systems) and VP of Genomics (Real Time Genetics, Omicia). Previously, he spent over 13 yeas at Applied Biosystems (later Life Technologies and currently Thermo-Fisher), where he played a pivotal role in the development of several successful genetic analysis technologies. For this, he was inducted in 2009 to the Innovation & Invention Society of Life Technologies, a program that recognized the company’s most elite inventors, and in 2008 was a co-recipient of the Bio-IT World Best Practices Award in Basic Research.
